Literature DB >> 6185955

Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells.

L P Turek, J C Byrne, D R Lowy, I Dvoretzky, R M Friedman, P M Howley.   

Abstract

The effect of mouse L-cell interferon on bovine papillomavirus type 1 (BPV-1) transformation of murine cells was examined. Mouse interferon reduced the level of BPV-1-induced transformation of mouse C127 cells by 95%. Long-term treatment of established BPV-1-transformed mouse cell clones with mouse L-cell interferon led to a decrease in the average number of the plasmid viral genomes present in these cells to 1/3 to 1/8. Although revertant lines could not be isolated from these lines in the absence of treatment with interferon, flat revertants were easily selected from two independent clonal transformed lines carried for 60 generations in the continued presence of 200 units of interferon per ml. These flat revertants had the biological characteristics of nontransformed C127 cells and could be retransformed by BPV-1. Southern blot hybridization failed to detect BPV-1 DNA in any of eight independent revertant lines examined under conditions that could detect 0.2 copies per cell. We conclude that interferon treatment has resulted in a selective reduction of the amount of extrachromosomal BPV-1 DNA in transformed cells and has cured some treated cells completely of their viral DNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185955      PMCID: PMC347460          DOI: 10.1073/pnas.79.24.7914

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  State of the viral DNA in rat cells transformed by polyma virus. II. Identification of the cells containing nonintegrated viral DNA and the effect of viral mutations.

Authors:  D Zouzias; I Prasad; C Basilico
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

2.  The arrangement of simian virus 40 sequences in the DNA of transformed cells.

Authors:  M Botchan; W Topp; J Sambrook
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

3.  Helper-independent transformation by unintegrated Harvey sarcoma virus DNA.

Authors:  D R Lowy; E Rands; E M Scolnick
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

4.  The effect of interferon on SV-40 T antigen production in SV-40-transformed cells.

Authors:  M N Oxman; S Baron; P H Black; K K Takemoto; K Habel; W P Rowe
Journal:  Virology       Date:  1967-05       Impact factor: 3.616

5.  The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3.

Authors:  G J Todaro; S Baron
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

6.  Inhibition of SV40 T antigen formation by interferon.

Authors:  M N Oxman; P H Black
Journal:  Proc Natl Acad Sci U S A       Date:  1966-05       Impact factor: 11.205

7.  Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome.

Authors:  P A Sharp; U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1974-07-15       Impact factor: 5.469

8.  Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose.

Authors:  C A Ogburn; K Berg; K Paucker
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

9.  Integrated simian virus 40 sequences in transformed cell DNA: analysis using restriction endonucleases.

Authors:  G Ketner; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

10.  Anatomy of herpes simplex virus DNA. VI. Defective DNA originates from the S component.

Authors:  N Frenkeĺ; H Locker; W Batterson; G S Hayward; B Roizman
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

View more
  31 in total

1.  The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication.

Authors:  Paramananda Saikia; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.

Authors:  J Monsonego; G Cessot; S E Ince; A R Galazka; A K Abdul-Ahad
Journal:  Genitourin Med       Date:  1996-04

3.  Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction.

Authors:  D R Hurwitz; R Hodges; W Drohan; N Sarver
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

4.  Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.

Authors:  Jianxin You; Michal-Ruth Schweiger; Peter M Howley
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 5.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 6.  [Warts and viruses].

Authors:  U Linz
Journal:  Naturwissenschaften       Date:  1988-05

7.  Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors.

Authors:  M Lusky; M R Botchan
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

Authors:  Yijan E Chang; Loren Pena; Ganes C Sen; Jung K Park; Laimonis A Laimins
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Constitutive production of human interferons by mouse cells with bovine papillomavirus as a vector.

Authors:  R Fukunaga; Y Sokawa; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 10.  Interferon for the treatment of genital warts: a systematic review.

Authors:  Jin Yang; Yu-Guo Pu; Zhong-Ming Zeng; Zhi-Jian Yu; Na Huang; Qi-Wen Deng
Journal:  BMC Infect Dis       Date:  2009-09-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.